Quest Diagnostics Incorporated (DGX)
NYSE: DGX · Real-Time Price · USD
182.18
-1.05 (-0.57%)
At close: Oct 24, 2025, 4:00 PM EDT
181.01
-1.17 (-0.64%)
After-hours: Oct 24, 2025, 7:51 PM EDT
Quest Diagnostics Employees
Quest Diagnostics had 56,000 employees as of December 31, 2024. The number of employees increased by 8,000 or 16.67% compared to the previous year.
Employees
56,000
Change (1Y)
8,000
Growth (1Y)
16.67%
Revenue / Employee
$193,750
Profits / Employee
$17,196
Market Cap
20.27B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 56,000 | 8,000 | 16.67% |
| Dec 31, 2023 | 48,000 | -1,000 | -2.04% |
| Dec 31, 2022 | 49,000 | 0 | - |
| Dec 31, 2021 | 49,000 | 0 | - |
| Dec 31, 2020 | 49,000 | 2,000 | 4.26% |
| Dec 31, 2019 | 47,000 | 1,000 | 2.17% |
| Dec 31, 2018 | 46,000 | 1,000 | 2.22% |
| Dec 31, 2017 | 45,000 | 2,000 | 4.65% |
| Dec 31, 2016 | 43,000 | -1,000 | -2.27% |
| Dec 31, 2015 | 44,000 | -1,000 | -2.22% |
| Dec 31, 2014 | 45,000 | 4,000 | 9.76% |
| Dec 31, 2013 | 41,000 | 0 | - |
| Dec 31, 2012 | 41,000 | -1,000 | -2.38% |
| Dec 31, 2011 | 42,000 | 0 | - |
| Dec 31, 2010 | 42,000 | -1,000 | -2.33% |
| Dec 31, 2009 | 43,000 | 200 | 0.47% |
| Dec 31, 2008 | 42,800 | -700 | -1.61% |
| Dec 31, 2007 | 43,500 | 2,500 | 6.10% |
| Dec 31, 2006 | 41,000 | -500 | -1.20% |
| Dec 31, 2005 | 41,500 | 2,900 | 7.51% |
| Dec 31, 2004 | 38,600 | 1,400 | 3.76% |
| Dec 31, 2003 | 37,200 | 3,800 | 11.38% |
| Dec 31, 2002 | 33,400 | 4,400 | 15.17% |
| Dec 31, 2001 | 29,000 | 2,000 | 7.41% |
| Dec 31, 2000 | 27,000 | 0 | - |
| Dec 31, 1999 | 27,000 | 12,000 | 80.00% |
| Dec 31, 1998 | 15,000 | -1,300 | -7.98% |
| Dec 31, 1997 | 16,300 | -1,500 | -8.43% |
| Dec 31, 1996 | 17,800 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
DGX News
- 4 days ago - Quest Diagnostics: Strong Q3, Steady (Not Spectacular) Growth Ahead - Seeking Alpha
- 4 days ago - Quest Diagnostics Analysts Increase Their Forecasts After Q3 Earnings - Benzinga
- 5 days ago - Quest Diagnostics Incorporated (DGX) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 5 days ago - Quest Diagnostics raises annual profit and revenue forecasts on lab test demand - Reuters
- 5 days ago - Quest Diagnostics Reports Third Quarter 2025 Financial Results; Raises Guidance for Full Year 2025 - PRNewsWire
- 20 days ago - Quest Diagnostics: Investing In Healthcare's Future Today - Seeking Alpha
- 26 days ago - Quest Diagnostics Incorporated (DGX) Presents at Jefferies 2025 Healthcare Services Conference Transcript - Seeking Alpha
- 4 weeks ago - Quest Diagnostics to Release Third Quarter 2025 Financial Results on October 21, 2025 - PRNewsWire